Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-01-506487
Filing Date
2001-04-02
Accepted
2001-04-02 00:00:00
Documents
5
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2034853z10-k.txt 10-K 229877
2 EXHIBIT 10.41 a2034853zex-10_41.txt EX-10.41 153032
3 EXHIBIT 10.42 a2034853zex-10_42.txt EX-10.42 77124
4 AUDITORS CONSENT a2034853zex-23_1.txt EX-23.1 463
5 EXHIBIT 99.1 a2034853zex-99_1.txt EX-99.1 40697
  Complete submission text file 0000912057-01-506487.txt   503136
Mailing Address FIVE SCIENCE PARK NEW HAVEN CT 06511
Business Address FIVE SCIENCE PARK NEW HAVEN CT 06511 2037731450
GENAISSANCE PHARMACEUTICALS INC (Filer) CIK: 0001110009 (see all company filings)

EIN.: 061338846 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30981 | Film No.: 1591712
SIC: 8731 Services-Commercial Physical & Biological Research